Stephen Daniel Bacchi, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Natural Language Processing | 16 | 2024 | 1203 | 3.540 |
Why?
|
Artificial Intelligence | 19 | 2024 | 2665 | 3.290 |
Why?
|
Australia | 30 | 2024 | 1265 | 2.780 |
Why?
|
Ophthalmology | 12 | 2024 | 560 | 1.870 |
Why?
|
Rural Health Services | 7 | 2024 | 394 | 1.720 |
Why?
|
Penicillins | 6 | 2024 | 406 | 1.680 |
Why?
|
Stroke | 15 | 2024 | 9755 | 1.660 |
Why?
|
Patient Discharge | 9 | 2024 | 3479 | 1.610 |
Why?
|
Students, Medical | 9 | 2024 | 1964 | 1.570 |
Why?
|
Myasthenia Gravis | 4 | 2023 | 215 | 1.530 |
Why?
|
Electronic Health Records | 13 | 2024 | 4887 | 1.310 |
Why?
|
Drug Hypersensitivity | 4 | 2024 | 923 | 1.150 |
Why?
|
Illusions | 2 | 2024 | 61 | 1.090 |
Why?
|
Length of Stay | 8 | 2024 | 6498 | 1.090 |
Why?
|
Vital Signs | 2 | 2024 | 146 | 1.010 |
Why?
|
Inpatients | 7 | 2024 | 2566 | 0.980 |
Why?
|
Delayed Graft Function | 1 | 2024 | 50 | 0.920 |
Why?
|
Hypersensitivity | 5 | 2023 | 1172 | 0.910 |
Why?
|
Humans | 179 | 2025 | 768166 | 0.900 |
Why?
|
Resuscitation Orders | 2 | 2024 | 271 | 0.890 |
Why?
|
Brain Ischemia | 6 | 2023 | 3007 | 0.870 |
Why?
|
Workflow | 3 | 2024 | 860 | 0.850 |
Why?
|
Cardiopulmonary Resuscitation | 4 | 2024 | 997 | 0.850 |
Why?
|
Hygiene | 1 | 2023 | 95 | 0.820 |
Why?
|
Licensure | 1 | 2023 | 127 | 0.810 |
Why?
|
Hospitals, Rural | 1 | 2024 | 174 | 0.810 |
Why?
|
Immunoglobulins, Intravenous | 2 | 2023 | 667 | 0.790 |
Why?
|
General Practice | 1 | 2023 | 101 | 0.790 |
Why?
|
South Australia | 7 | 2024 | 27 | 0.770 |
Why?
|
Guillain-Barre Syndrome | 1 | 2023 | 127 | 0.760 |
Why?
|
Consciousness | 3 | 2023 | 602 | 0.750 |
Why?
|
Environment | 2 | 2024 | 1121 | 0.750 |
Why?
|
Unconsciousness | 1 | 2023 | 251 | 0.740 |
Why?
|
Valproic Acid | 1 | 2024 | 444 | 0.740 |
Why?
|
Documentation | 2 | 2024 | 917 | 0.720 |
Why?
|
Computers | 1 | 2023 | 592 | 0.720 |
Why?
|
Hematinics | 1 | 2023 | 282 | 0.700 |
Why?
|
Resilience, Psychological | 2 | 2020 | 807 | 0.690 |
Why?
|
Clinical Coding | 1 | 2021 | 188 | 0.680 |
Why?
|
Risk Management | 1 | 2023 | 558 | 0.680 |
Why?
|
Anaphylaxis | 2 | 2024 | 758 | 0.640 |
Why?
|
Arterial Occlusive Diseases | 1 | 2023 | 744 | 0.630 |
Why?
|
Renal Dialysis | 2 | 2024 | 1791 | 0.600 |
Why?
|
Food | 1 | 2023 | 768 | 0.590 |
Why?
|
Epilepsy | 2 | 2024 | 3327 | 0.590 |
Why?
|
Patient Readmission | 5 | 2024 | 3288 | 0.590 |
Why?
|
Rural Population | 4 | 2024 | 2325 | 0.590 |
Why?
|
Ischemic Attack, Transient | 2 | 2023 | 877 | 0.580 |
Why?
|
LDL-Receptor Related Proteins | 1 | 2018 | 118 | 0.570 |
Why?
|
Delivery of Health Care | 3 | 2024 | 5367 | 0.570 |
Why?
|
Hypotension, Orthostatic | 2 | 2019 | 258 | 0.570 |
Why?
|
Algorithms | 11 | 2024 | 14164 | 0.570 |
Why?
|
Domperidone | 1 | 2017 | 24 | 0.560 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2023 | 716 | 0.550 |
Why?
|
Hand | 1 | 2022 | 913 | 0.550 |
Why?
|
Neurosurgical Procedures | 3 | 2023 | 2076 | 0.550 |
Why?
|
Supranuclear Palsy, Progressive | 1 | 2017 | 82 | 0.550 |
Why?
|
Defibrillators | 4 | 2023 | 39 | 0.540 |
Why?
|
Checklist | 1 | 2024 | 840 | 0.540 |
Why?
|
Physical Examination | 1 | 2022 | 1263 | 0.530 |
Why?
|
Glucocorticoids | 3 | 2024 | 2167 | 0.520 |
Why?
|
Cerebrovascular Disorders | 2 | 2023 | 1485 | 0.520 |
Why?
|
Students | 3 | 2023 | 1744 | 0.520 |
Why?
|
Dopamine Antagonists | 1 | 2017 | 284 | 0.510 |
Why?
|
New Zealand | 6 | 2024 | 360 | 0.490 |
Why?
|
Hospital Mortality | 4 | 2024 | 5349 | 0.480 |
Why?
|
Out-of-Hospital Cardiac Arrest | 3 | 2023 | 340 | 0.480 |
Why?
|
Education, Medical | 3 | 2024 | 1742 | 0.470 |
Why?
|
Statistics as Topic | 1 | 2021 | 2357 | 0.470 |
Why?
|
Forecasting | 2 | 2021 | 2945 | 0.450 |
Why?
|
Seizures | 2 | 2024 | 2998 | 0.450 |
Why?
|
Anticonvulsants | 1 | 2024 | 1923 | 0.450 |
Why?
|
Pilot Projects | 9 | 2024 | 8741 | 0.440 |
Why?
|
Retrospective Studies | 30 | 2024 | 81762 | 0.440 |
Why?
|
Education, Medical, Undergraduate | 2 | 2024 | 1085 | 0.420 |
Why?
|
Perioperative Period | 2 | 2024 | 253 | 0.420 |
Why?
|
Circadian Rhythm | 1 | 2024 | 2593 | 0.410 |
Why?
|
Stress, Psychological | 2 | 2020 | 4530 | 0.410 |
Why?
|
Nervous System Diseases | 1 | 2023 | 1662 | 0.400 |
Why?
|
Aortic Valve Stenosis | 1 | 2025 | 2032 | 0.400 |
Why?
|
Endovascular Procedures | 3 | 2024 | 2216 | 0.400 |
Why?
|
Palliative Care | 2 | 2024 | 3643 | 0.390 |
Why?
|
Hospitalization | 5 | 2023 | 10840 | 0.370 |
Why?
|
Curriculum | 6 | 2024 | 3782 | 0.370 |
Why?
|
Specialties, Surgical | 3 | 2024 | 391 | 0.360 |
Why?
|
General Surgery | 5 | 2024 | 1720 | 0.340 |
Why?
|
Kidney Transplantation | 1 | 2024 | 4262 | 0.320 |
Why?
|
Autoantibodies | 1 | 2018 | 2121 | 0.320 |
Why?
|
Magnetic Resonance Imaging | 7 | 2024 | 36743 | 0.320 |
Why?
|
Thrombectomy | 3 | 2024 | 676 | 0.310 |
Why?
|
Aged | 24 | 2024 | 171504 | 0.300 |
Why?
|
Electroencephalography | 1 | 2024 | 6314 | 0.300 |
Why?
|
Periodicals as Topic | 3 | 2024 | 1465 | 0.300 |
Why?
|
Atrial Fibrillation | 3 | 2023 | 5176 | 0.300 |
Why?
|
Area Under Curve | 3 | 2021 | 1643 | 0.290 |
Why?
|
Databases, Bibliographic | 2 | 2018 | 128 | 0.280 |
Why?
|
Registries | 1 | 2023 | 8375 | 0.270 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2019 | 3390 | 0.270 |
Why?
|
Educational Measurement | 2 | 2024 | 1260 | 0.270 |
Why?
|
Parkinson Disease | 2 | 2019 | 2893 | 0.260 |
Why?
|
Cultural Diversity | 3 | 2024 | 373 | 0.260 |
Why?
|
Time Factors | 7 | 2024 | 40218 | 0.260 |
Why?
|
Medicare | 2 | 2023 | 6809 | 0.250 |
Why?
|
Middle Aged | 21 | 2024 | 223492 | 0.250 |
Why?
|
Physicians | 1 | 2023 | 4598 | 0.250 |
Why?
|
Telemedicine | 1 | 2023 | 3109 | 0.250 |
Why?
|
Vitreoretinal Surgery | 1 | 2024 | 28 | 0.240 |
Why?
|
Food Service, Hospital | 1 | 2024 | 18 | 0.230 |
Why?
|
Anticoagulants | 4 | 2023 | 4852 | 0.230 |
Why?
|
Male | 28 | 2024 | 364719 | 0.230 |
Why?
|
Camelids, New World | 1 | 2024 | 20 | 0.230 |
Why?
|
Glioma | 1 | 2019 | 3503 | 0.230 |
Why?
|
Universal Precautions | 1 | 2023 | 34 | 0.220 |
Why?
|
Surgical Wound Infection | 2 | 2023 | 1546 | 0.220 |
Why?
|
Rheumatic Fever | 1 | 2024 | 73 | 0.220 |
Why?
|
Intubation | 1 | 2024 | 140 | 0.220 |
Why?
|
Cerebrospinal Fluid Proteins | 1 | 2023 | 71 | 0.220 |
Why?
|
Electric Countershock | 2 | 2023 | 534 | 0.220 |
Why?
|
Authorship | 2 | 2023 | 289 | 0.220 |
Why?
|
Female | 27 | 2024 | 397192 | 0.220 |
Why?
|
Reperfusion | 1 | 2024 | 266 | 0.220 |
Why?
|
Medical Audit | 1 | 2024 | 454 | 0.210 |
Why?
|
Tramadol | 1 | 2023 | 63 | 0.210 |
Why?
|
Surgery Department, Hospital | 1 | 2024 | 170 | 0.210 |
Why?
|
Decompressive Craniectomy | 1 | 2023 | 76 | 0.210 |
Why?
|
Rural Health | 1 | 2024 | 302 | 0.210 |
Why?
|
Respiratory Rate | 1 | 2024 | 180 | 0.200 |
Why?
|
Risk Factors | 12 | 2025 | 74944 | 0.200 |
Why?
|
Rheumatic Heart Disease | 1 | 2024 | 164 | 0.200 |
Why?
|
Food Handling | 1 | 2023 | 158 | 0.200 |
Why?
|
Injections, Subcutaneous | 1 | 2024 | 687 | 0.200 |
Why?
|
Dupuytren Contracture | 1 | 2023 | 66 | 0.200 |
Why?
|
Hematologic Tests | 1 | 2023 | 239 | 0.200 |
Why?
|
Aerospace Medicine | 1 | 2023 | 95 | 0.200 |
Why?
|
Methylprednisolone | 1 | 2023 | 386 | 0.200 |
Why?
|
Triage | 2 | 2019 | 997 | 0.200 |
Why?
|
Linguistics | 1 | 2022 | 110 | 0.200 |
Why?
|
Adrenal Insufficiency | 1 | 2024 | 195 | 0.200 |
Why?
|
Basilar Artery | 1 | 2023 | 207 | 0.200 |
Why?
|
Pneumonia, Pneumocystis | 1 | 2023 | 242 | 0.190 |
Why?
|
Breath Tests | 1 | 2023 | 300 | 0.190 |
Why?
|
Blepharoptosis | 1 | 2023 | 144 | 0.190 |
Why?
|
Antiemetics | 1 | 2023 | 188 | 0.190 |
Why?
|
Anti-Bacterial Agents | 4 | 2024 | 7477 | 0.190 |
Why?
|
Prognosis | 3 | 2024 | 30010 | 0.190 |
Why?
|
Optic Neuropathy, Ischemic | 1 | 2023 | 87 | 0.190 |
Why?
|
Emergency Medical Services | 2 | 2023 | 1947 | 0.190 |
Why?
|
Optic Neuritis | 1 | 2023 | 175 | 0.190 |
Why?
|
Adrenal Glands | 1 | 2024 | 557 | 0.190 |
Why?
|
Positron-Emission Tomography | 1 | 2018 | 6669 | 0.190 |
Why?
|
Anti-Infective Agents, Local | 1 | 2023 | 247 | 0.190 |
Why?
|
Cultural Competency | 1 | 2024 | 303 | 0.180 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2019 | 9419 | 0.180 |
Why?
|
Preoperative Care | 3 | 2024 | 2258 | 0.180 |
Why?
|
Vasospasm, Intracranial | 1 | 2023 | 207 | 0.180 |
Why?
|
Costs and Cost Analysis | 2 | 2023 | 1667 | 0.180 |
Why?
|
Marketing | 1 | 2022 | 224 | 0.180 |
Why?
|
Intensive Care Units | 2 | 2024 | 3800 | 0.170 |
Why?
|
Adverse Drug Reaction Reporting Systems | 1 | 2024 | 496 | 0.170 |
Why?
|
Epinephrine | 1 | 2024 | 794 | 0.170 |
Why?
|
Depression | 2 | 2023 | 8230 | 0.170 |
Why?
|
Vitrectomy | 1 | 2023 | 392 | 0.170 |
Why?
|
Blood Glucose | 2 | 2024 | 6430 | 0.170 |
Why?
|
Macular Edema | 1 | 2024 | 387 | 0.170 |
Why?
|
Spirometry | 1 | 2023 | 929 | 0.170 |
Why?
|
Patients' Rooms | 1 | 2020 | 63 | 0.170 |
Why?
|
Thyrotropin | 1 | 2023 | 834 | 0.170 |
Why?
|
Patients | 2 | 2023 | 908 | 0.170 |
Why?
|
Waiting Lists | 1 | 2024 | 779 | 0.170 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2023 | 614 | 0.160 |
Why?
|
Publishing | 2 | 2024 | 837 | 0.160 |
Why?
|
Language | 3 | 2024 | 1557 | 0.160 |
Why?
|
Risk Assessment | 5 | 2025 | 24315 | 0.160 |
Why?
|
Cross-Sectional Studies | 5 | 2024 | 26379 | 0.160 |
Why?
|
Students, Nursing | 1 | 2019 | 46 | 0.160 |
Why?
|
Giant Cell Arteritis | 1 | 2023 | 307 | 0.160 |
Why?
|
Optic Nerve Diseases | 1 | 2023 | 342 | 0.160 |
Why?
|
Pain, Postoperative | 3 | 2024 | 1765 | 0.160 |
Why?
|
Postoperative Complications | 6 | 2024 | 15832 | 0.160 |
Why?
|
Databases, Factual | 3 | 2024 | 8080 | 0.160 |
Why?
|
Training Support | 1 | 2019 | 109 | 0.160 |
Why?
|
Cataract Extraction | 1 | 2023 | 464 | 0.160 |
Why?
|
Referral and Consultation | 2 | 2024 | 3620 | 0.160 |
Why?
|
Reading | 1 | 2022 | 543 | 0.160 |
Why?
|
Serotonin | 1 | 2023 | 1043 | 0.160 |
Why?
|
Conflict of Interest | 1 | 2023 | 556 | 0.150 |
Why?
|
Vitiligo | 1 | 2019 | 97 | 0.150 |
Why?
|
Food Supply | 1 | 2024 | 544 | 0.150 |
Why?
|
Eye Diseases | 2 | 2024 | 660 | 0.150 |
Why?
|
Hyperlipidemias | 1 | 2023 | 772 | 0.150 |
Why?
|
History, 21st Century | 1 | 2024 | 1573 | 0.150 |
Why?
|
Malnutrition | 1 | 2024 | 632 | 0.150 |
Why?
|
Brain Neoplasms | 1 | 2019 | 9118 | 0.150 |
Why?
|
Health Literacy | 1 | 2023 | 466 | 0.150 |
Why?
|
Schools, Medical | 2 | 2024 | 883 | 0.140 |
Why?
|
Drug Monitoring | 1 | 2023 | 964 | 0.140 |
Why?
|
Endarterectomy, Carotid | 1 | 2022 | 556 | 0.140 |
Why?
|
Hearing Loss, Sensorineural | 1 | 2023 | 783 | 0.140 |
Why?
|
Treatment Outcome | 9 | 2024 | 65371 | 0.140 |
Why?
|
Hypoglycemia | 1 | 2024 | 895 | 0.140 |
Why?
|
Terminology as Topic | 1 | 2024 | 1542 | 0.140 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2023 | 704 | 0.140 |
Why?
|
Hydrocephalus | 1 | 2023 | 768 | 0.140 |
Why?
|
Carotid Artery Diseases | 1 | 2023 | 879 | 0.140 |
Why?
|
False Positive Reactions | 1 | 2019 | 963 | 0.130 |
Why?
|
Tomography, Optical Coherence | 3 | 2024 | 2957 | 0.130 |
Why?
|
Appendicitis | 1 | 2023 | 690 | 0.130 |
Why?
|
Reference Values | 1 | 2023 | 4938 | 0.130 |
Why?
|
Information Storage and Retrieval | 1 | 2022 | 830 | 0.130 |
Why?
|
History, 20th Century | 1 | 2024 | 2766 | 0.130 |
Why?
|
Adult | 13 | 2024 | 223646 | 0.130 |
Why?
|
Infarction, Middle Cerebral Artery | 1 | 2019 | 486 | 0.130 |
Why?
|
Otolaryngology | 1 | 2023 | 699 | 0.130 |
Why?
|
Hyperglycemia | 1 | 2024 | 1388 | 0.130 |
Why?
|
Cooperative Behavior | 1 | 2023 | 1514 | 0.130 |
Why?
|
Evidence-Based Medicine | 2 | 2024 | 3706 | 0.130 |
Why?
|
Macular Degeneration | 1 | 2023 | 1015 | 0.130 |
Why?
|
Universities | 2 | 2023 | 1005 | 0.120 |
Why?
|
Aged, 80 and over | 6 | 2024 | 59629 | 0.120 |
Why?
|
Carotid Stenosis | 1 | 2022 | 859 | 0.120 |
Why?
|
Vascular Surgical Procedures | 1 | 2024 | 1506 | 0.120 |
Why?
|
Intubation, Intratracheal | 1 | 2023 | 1359 | 0.120 |
Why?
|
Aortic Valve | 1 | 2025 | 1970 | 0.120 |
Why?
|
Internationality | 1 | 2020 | 1008 | 0.120 |
Why?
|
Thrombolytic Therapy | 2 | 2024 | 2055 | 0.120 |
Why?
|
Patient Education as Topic | 1 | 2024 | 2337 | 0.110 |
Why?
|
Sulfonamides | 1 | 2024 | 1982 | 0.110 |
Why?
|
Neuroma, Acoustic | 1 | 2018 | 455 | 0.110 |
Why?
|
Leadership | 1 | 2023 | 1397 | 0.110 |
Why?
|
Automobile Driving | 1 | 2019 | 442 | 0.110 |
Why?
|
Prospective Studies | 7 | 2024 | 54926 | 0.110 |
Why?
|
Psychology | 1 | 2016 | 353 | 0.110 |
Why?
|
Cause of Death | 1 | 2025 | 3721 | 0.110 |
Why?
|
Neurodegenerative Diseases | 1 | 2023 | 1095 | 0.110 |
Why?
|
Orthopedics | 1 | 2023 | 906 | 0.110 |
Why?
|
Biomedical Research | 3 | 2024 | 3463 | 0.110 |
Why?
|
Risk-Taking | 1 | 2019 | 1023 | 0.110 |
Why?
|
Graft Survival | 1 | 2024 | 3887 | 0.110 |
Why?
|
Software | 3 | 2022 | 4478 | 0.110 |
Why?
|
Dermatology | 1 | 2023 | 905 | 0.110 |
Why?
|
Feasibility Studies | 1 | 2024 | 5315 | 0.110 |
Why?
|
School Admission Criteria | 2 | 2024 | 107 | 0.110 |
Why?
|
Logistic Models | 3 | 2024 | 13290 | 0.110 |
Why?
|
ROC Curve | 1 | 2021 | 3628 | 0.100 |
Why?
|
Kidney Diseases | 1 | 2024 | 2100 | 0.100 |
Why?
|
Internship and Residency | 2 | 2024 | 5953 | 0.100 |
Why?
|
Patient Care Team | 1 | 2024 | 2523 | 0.100 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2024 | 2145 | 0.100 |
Why?
|
Career Choice | 1 | 2019 | 769 | 0.100 |
Why?
|
Hospitals | 2 | 2024 | 3886 | 0.100 |
Why?
|
Patient-Centered Care | 1 | 2023 | 1444 | 0.100 |
Why?
|
Sleep Deprivation | 1 | 2019 | 848 | 0.100 |
Why?
|
Wound Healing | 1 | 2023 | 2809 | 0.100 |
Why?
|
Heart Rate | 1 | 2024 | 4214 | 0.100 |
Why?
|
Respiration, Artificial | 1 | 2023 | 2726 | 0.100 |
Why?
|
Outpatients | 1 | 2019 | 1600 | 0.090 |
Why?
|
Sleep | 2 | 2024 | 4819 | 0.090 |
Why?
|
Cardiac Surgical Procedures | 2 | 2024 | 3683 | 0.090 |
Why?
|
Clinical Competence | 2 | 2024 | 4858 | 0.090 |
Why?
|
Administration, Oral | 3 | 2023 | 4030 | 0.090 |
Why?
|
Hip Fractures | 1 | 2019 | 997 | 0.090 |
Why?
|
Analgesics, Opioid | 2 | 2024 | 3837 | 0.090 |
Why?
|
Hemorrhage | 1 | 2023 | 3467 | 0.090 |
Why?
|
Ventricular Function, Left | 1 | 2024 | 3941 | 0.090 |
Why?
|
Internet | 1 | 2023 | 3110 | 0.090 |
Why?
|
Deep Brain Stimulation | 1 | 2019 | 851 | 0.090 |
Why?
|
Survival Rate | 1 | 2025 | 12840 | 0.090 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2019 | 1560 | 0.090 |
Why?
|
Headache | 1 | 2018 | 1263 | 0.080 |
Why?
|
Venous Thromboembolism | 1 | 2023 | 1883 | 0.080 |
Why?
|
Vitamin D | 1 | 2023 | 3311 | 0.080 |
Why?
|
Multiple Sclerosis | 1 | 2024 | 3250 | 0.080 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2018 | 2055 | 0.080 |
Why?
|
Health Services Accessibility | 2 | 2023 | 5520 | 0.080 |
Why?
|
Demography | 2 | 2024 | 1641 | 0.080 |
Why?
|
Diagnosis, Differential | 1 | 2024 | 13014 | 0.080 |
Why?
|
Death, Sudden, Cardiac | 1 | 2017 | 1567 | 0.080 |
Why?
|
Cohort Studies | 4 | 2024 | 41754 | 0.080 |
Why?
|
Life Style | 1 | 2020 | 3932 | 0.080 |
Why?
|
Tachycardia, Ventricular | 1 | 2017 | 1309 | 0.070 |
Why?
|
Education, Medical, Graduate | 3 | 2024 | 2420 | 0.070 |
Why?
|
Pain | 1 | 2022 | 5100 | 0.070 |
Why?
|
Disease Progression | 1 | 2024 | 13671 | 0.070 |
Why?
|
Arrhythmias, Cardiac | 1 | 2017 | 2258 | 0.070 |
Why?
|
Predictive Value of Tests | 2 | 2024 | 15454 | 0.070 |
Why?
|
Graft vs Host Disease | 1 | 2019 | 3049 | 0.070 |
Why?
|
Sensitivity and Specificity | 2 | 2023 | 14729 | 0.070 |
Why?
|
United States | 3 | 2023 | 73039 | 0.060 |
Why?
|
Educational Status | 2 | 2023 | 2515 | 0.060 |
Why?
|
Depressive Disorder, Major | 1 | 2023 | 4818 | 0.060 |
Why?
|
Mental Health | 1 | 2019 | 3275 | 0.060 |
Why?
|
Skin Neoplasms | 1 | 2024 | 5863 | 0.060 |
Why?
|
Vitreous Detachment | 1 | 2024 | 23 | 0.060 |
Why?
|
Primary Health Care | 1 | 2021 | 4746 | 0.060 |
Why?
|
Visual Acuity | 2 | 2024 | 2714 | 0.060 |
Why?
|
Neoplasms | 2 | 2023 | 22371 | 0.060 |
Why?
|
Serotonin 5-HT3 Receptor Antagonists | 1 | 2023 | 23 | 0.060 |
Why?
|
Povidone-Iodine | 1 | 2023 | 56 | 0.050 |
Why?
|
Nimodipine | 1 | 2023 | 56 | 0.050 |
Why?
|
2-Propanol | 1 | 2023 | 28 | 0.050 |
Why?
|
Prone Position | 1 | 2024 | 203 | 0.050 |
Why?
|
Depth Perception | 1 | 2023 | 94 | 0.050 |
Why?
|
New South Wales | 1 | 2023 | 69 | 0.050 |
Why?
|
Hypertension | 1 | 2023 | 8616 | 0.050 |
Why?
|
Sunscreening Agents | 1 | 2024 | 139 | 0.050 |
Why?
|
Coronary Artery Disease | 1 | 2023 | 6568 | 0.050 |
Why?
|
Journal Impact Factor | 1 | 2024 | 157 | 0.050 |
Why?
|
Surgical Procedures, Operative | 2 | 2024 | 1932 | 0.050 |
Why?
|
Collagenases | 1 | 2023 | 221 | 0.050 |
Why?
|
Verapamil | 1 | 2023 | 242 | 0.050 |
Why?
|
Carbamazepine | 1 | 2023 | 224 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 2 | 2024 | 20760 | 0.050 |
Why?
|
Personnel Selection | 1 | 2024 | 201 | 0.050 |
Why?
|
Hospitals, Public | 1 | 2024 | 204 | 0.050 |
Why?
|
Oxycodone | 1 | 2023 | 144 | 0.050 |
Why?
|
Vitreous Body | 1 | 2024 | 401 | 0.050 |
Why?
|
Ukraine | 1 | 2022 | 151 | 0.050 |
Why?
|
Publication Bias | 1 | 2022 | 158 | 0.050 |
Why?
|
Bandages | 1 | 2023 | 272 | 0.050 |
Why?
|
Ophthalmic Solutions | 1 | 2023 | 312 | 0.050 |
Why?
|
Russia | 1 | 2022 | 386 | 0.050 |
Why?
|
Systole | 1 | 2024 | 937 | 0.050 |
Why?
|
Health Occupations | 1 | 2023 | 225 | 0.050 |
Why?
|
Odds Ratio | 2 | 2024 | 9669 | 0.050 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2019 | 5717 | 0.050 |
Why?
|
Electronics | 1 | 2022 | 317 | 0.050 |
Why?
|
Pharynx | 1 | 2023 | 436 | 0.040 |
Why?
|
Bibliometrics | 1 | 2024 | 354 | 0.040 |
Why?
|
Nausea | 1 | 2023 | 682 | 0.040 |
Why?
|
Glucagon-Like Peptide 1 | 1 | 2023 | 374 | 0.040 |
Why?
|
Vasoconstriction | 1 | 2023 | 592 | 0.040 |
Why?
|
Thinness | 1 | 2023 | 483 | 0.040 |
Why?
|
National Health Programs | 1 | 2023 | 442 | 0.040 |
Why?
|
Cost-Benefit Analysis | 2 | 2023 | 5536 | 0.040 |
Why?
|
Communication Barriers | 1 | 2023 | 419 | 0.040 |
Why?
|
Nose | 1 | 2023 | 522 | 0.040 |
Why?
|
Leukocyte Count | 1 | 2023 | 1609 | 0.040 |
Why?
|
Confidentiality | 1 | 2023 | 607 | 0.040 |
Why?
|
Delayed Diagnosis | 1 | 2023 | 467 | 0.040 |
Why?
|
Video Recording | 1 | 2024 | 976 | 0.040 |
Why?
|
Frail Elderly | 1 | 2024 | 781 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2023 | 12252 | 0.040 |
Why?
|
Automation | 1 | 2021 | 589 | 0.040 |
Why?
|
Sample Size | 1 | 2022 | 846 | 0.040 |
Why?
|
Prednisone | 1 | 2023 | 1567 | 0.040 |
Why?
|
Medical Staff, Hospital | 1 | 2023 | 603 | 0.040 |
Why?
|
Veins | 1 | 2023 | 769 | 0.040 |
Why?
|
Netherlands | 1 | 2023 | 2277 | 0.040 |
Why?
|
Peer Group | 1 | 2024 | 700 | 0.040 |
Why?
|
Globus Pallidus | 1 | 2019 | 248 | 0.040 |
Why?
|
Retinal Diseases | 1 | 2024 | 710 | 0.040 |
Why?
|
Syndrome | 1 | 2024 | 3272 | 0.040 |
Why?
|
Angiography | 1 | 2023 | 1597 | 0.040 |
Why?
|
Canada | 1 | 2023 | 2130 | 0.040 |
Why?
|
Fluorescein Angiography | 1 | 2023 | 1086 | 0.040 |
Why?
|
Gastrointestinal Tract | 1 | 2023 | 840 | 0.040 |
Why?
|
Cardiovascular Diseases | 1 | 2023 | 15662 | 0.040 |
Why?
|
Benzodiazepines | 1 | 2023 | 1138 | 0.040 |
Why?
|
Cisplatin | 1 | 2023 | 1660 | 0.030 |
Why?
|
Retinal Vessels | 1 | 2023 | 864 | 0.030 |
Why?
|
Photic Stimulation | 1 | 2023 | 1997 | 0.030 |
Why?
|
Informed Consent | 1 | 2023 | 1010 | 0.030 |
Why?
|
Geriatric Assessment | 1 | 2024 | 1422 | 0.030 |
Why?
|
Europe | 1 | 2023 | 3436 | 0.030 |
Why?
|
Subthalamic Nucleus | 1 | 2019 | 203 | 0.030 |
Why?
|
Nutritional Status | 1 | 2024 | 1628 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2023 | 10399 | 0.030 |
Why?
|
Social Class | 1 | 2024 | 2008 | 0.030 |
Why?
|
Faculty, Medical | 1 | 2024 | 1226 | 0.030 |
Why?
|
Pharmaceutical Preparations | 1 | 2023 | 1088 | 0.030 |
Why?
|
Colonoscopy | 1 | 2023 | 1409 | 0.030 |
Why?
|
Linear Models | 1 | 2024 | 5884 | 0.030 |
Why?
|
Prevalence | 2 | 2023 | 15869 | 0.030 |
Why?
|
Specialization | 1 | 2019 | 779 | 0.030 |
Why?
|
Reoperation | 1 | 2024 | 4329 | 0.030 |
Why?
|
Angiogenesis Inhibitors | 1 | 2024 | 2056 | 0.030 |
Why?
|
Coronary Artery Bypass | 1 | 2023 | 2191 | 0.030 |
Why?
|
Disease Management | 1 | 2024 | 2536 | 0.030 |
Why?
|
Incidence | 2 | 2023 | 21538 | 0.030 |
Why?
|
Cerebral Hemorrhage | 1 | 2024 | 2655 | 0.030 |
Why?
|
Acute Disease | 1 | 2023 | 7243 | 0.030 |
Why?
|
Anxiety Disorders | 1 | 2023 | 2748 | 0.020 |
Why?
|
Weight Loss | 1 | 2023 | 2721 | 0.020 |
Why?
|
Adolescent | 2 | 2019 | 89169 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2023 | 3858 | 0.020 |
Why?
|
Echocardiography | 1 | 2024 | 5047 | 0.020 |
Why?
|
Hypoglycemic Agents | 1 | 2023 | 3109 | 0.020 |
Why?
|
Sex Factors | 1 | 2024 | 10632 | 0.020 |
Why?
|
Health Personnel | 1 | 2023 | 3385 | 0.020 |
Why?
|
Stroke Volume | 1 | 2024 | 5622 | 0.020 |
Why?
|
Diagnostic Imaging | 1 | 2024 | 3533 | 0.020 |
Why?
|
Animals | 2 | 2024 | 169246 | 0.020 |
Why?
|
Tissue Donors | 1 | 2019 | 2381 | 0.020 |
Why?
|
Young Adult | 1 | 2016 | 60066 | 0.020 |
Why?
|
Opioid-Related Disorders | 1 | 2024 | 2188 | 0.020 |
Why?
|
Comorbidity | 1 | 2024 | 10590 | 0.020 |
Why?
|
Communication | 1 | 2023 | 3905 | 0.020 |
Why?
|
Healthcare Disparities | 1 | 2024 | 3415 | 0.020 |
Why?
|
Anxiety | 1 | 2023 | 4672 | 0.020 |
Why?
|
Age Factors | 1 | 2024 | 18412 | 0.020 |
Why?
|
Blood Pressure | 1 | 2023 | 8543 | 0.020 |
Why?
|
Quality Improvement | 1 | 2023 | 3857 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2023 | 8054 | 0.020 |
Why?
|
Diabetes Mellitus | 1 | 2024 | 5889 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2023 | 9263 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2024 | 20227 | 0.020 |
Why?
|
Child | 2 | 2023 | 80917 | 0.020 |
Why?
|
Quality of Life | 1 | 2023 | 13490 | 0.010 |
Why?
|
Heart Failure | 1 | 2024 | 11879 | 0.010 |
Why?
|